Nicola Squillace Selected Research

Nicola Squillace Research Topics

Disease

6	HIV Infections (HIV Infection) 03/2022 - 07/2009
4	COVID-19 10/2021 - 10/2020
4	Pneumonia (Pneumonitis) 10/2021 - 10/2020
4	Insulin Resistance 01/2019 - 05/2006
4	Infections 10/2017 - 03/2014
4	Lipodystrophy 01/2017 - 05/2006
3	Hypercholesterolemia 01/2019 - 05/2006
3	Hypertriglyceridemia 01/2019 - 05/2006
3	Cardiovascular Diseases (Cardiovascular Disease) 04/2017 - 07/2008
2	Dyslipidemias (Dyslipidemia) 01/2017 - 07/2009
2	Non-alcoholic Fatty Liver Disease 02/2010 - 07/2008
1	Melanoma (Melanoma, Malignant) 03/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 03/2022
1	Cytomegalovirus Infections (Inclusion Disease) 01/2021
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2021
1	Weight Gain 06/2020
1	Osteoporosis 01/2020
1	Coinfection 01/2020
1	Metabolic Bone Diseases (Osteopenia) 01/2020
1	Inflammation (Inflammations) 01/2020
1	Tobacco Use Disorder (Nicotine Dependence) 01/2020
1	Neoplasms (Cancer) 09/2016
1	Diabetes Mellitus 01/2016
1	Chronic Renal Insufficiency 06/2015
1	Exanthema (Rash) 05/2015
1	HIV-Associated Lipodystrophy Syndrome 11/2014
1	Disease Progression 12/2009
1	Viremia 12/2009
1	Hypertension (High Blood Pressure) 07/2009
1	Vascular Remodeling 07/2009
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2009
1	Atherosclerosis 07/2008
1	Erectile Dysfunction 01/2007
1	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2007
1	Aspergillosis 01/2005
1	Weil Disease (Weil's Disease) 01/2005

Drug/Important Bio-Agent (IBA)

5	Protease Inhibitors (Protease Inhibitor)IBA 01/2019 - 12/2010
4	tocilizumab (atlizumab)FDA Link 10/2021 - 10/2020
4	HDL CholesterolIBA 01/2020 - 07/2008
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019 - 01/2017
3	NucleosidesIBA 01/2019 - 07/2008
3	Reverse Transcriptase InhibitorsIBA 01/2019 - 07/2008
2	MicroRNAs (MicroRNA)IBA 03/2022 - 11/2014
2	Integrase InhibitorsIBA 01/2021 - 01/2017
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 10/2020
2	RNA (Ribonucleic Acid)IBA 01/2020 - 09/2016
2	Triglycerides (Triacylglycerol)IBA 01/2019 - 01/2016
2	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 05/2006
2	oxidized low density lipoproteinIBA 01/2019 - 05/2006
2	LipidsIBA 01/2019 - 01/2017
2	CholesterolIBA 01/2019 - 07/2008
2	Fibric Acids (Fibrates)IBA 01/2019 - 01/2017
2	Tenofovir (Viread)FDA Link 10/2017 - 03/2014
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2017 - 07/2008
1	Nerve Growth Factors (Neurotrophins)IBA 03/2022
1	Insulin (Novolin)FDA Link 03/2022
1	CytokinesIBA 01/2021
1	dolutegravirIBA 06/2020
1	Vitamin D FDA LinkGeneric 01/2020
1	CobicistatIBA 01/2018
1	Darunavir (Prezista)FDA Link 01/2018
1	Emtricitabine (Emtriva)FDA Link 01/2018
1	tenofovir alafenamideIBA 01/2018
1	RacivirIBA 01/2018
1	TabletsIBA 01/2018
1	sofosbuvir drug combination ledipasvirIBA 10/2017
1	beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA 10/2017
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 04/2017
1	Alanine Transaminase (SGPT)IBA 01/2017
1	HDL-triglycerideIBA 01/2016
1	telaprevirIBA 05/2015
1	Antiviral Agents (Antivirals)IBA 03/2014
1	Aspartic Acid (Aspartate)FDA Link 07/2008
1	CalciumIBA 07/2008
1	Alanine (L-Alanine)FDA Link 07/2008
1	Testosterone (Sustanon)FDA Link 01/2007
1	liposomal amphotericin B FDA Link 01/2005
1	Voriconazole (Vfend)FDA LinkGeneric 01/2005

Therapy/Procedure

13	Therapeutics 01/2021 - 01/2005
4	Highly Active Antiretroviral Therapy (HAART) 06/2015 - 01/2007
1	Artificial Respiration (Mechanical Ventilation) 01/2021
1	Critical Care (Surgical Intensive Care) 01/2021
1	Physical Therapy Modalities (Physical Therapy Technique) 05/2006